- Home
- MPTI vs CGTX Comparison
MPTI vs CGTX Comparison
Compare MPTI & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPTI | CGTX |
|---|---|---|
| Founded | 1965 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.9M | 132.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MPTI | CGTX |
|---|---|---|
| Price | $51.20 | $1.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.88 |
| AVG Volume (30 Days) | 30.6K | ★ 957.8K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.64 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | ★ $52,989,000.00 | N/A |
| Revenue This Year | $13.32 | N/A |
| Revenue Next Year | $10.56 | N/A |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $34.50 | $0.22 |
| 52 Week High | $61.91 | $3.83 |
Technical Indicators
Market Signals| Indicator | MPTI | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.33 | 43.72 |
| Support Level | $49.67 | $1.37 |
| Resistance Level | $54.65 | $1.62 |
| Average True Range (ATR) | 1.83 | 0.12 |
| MACD | -0.24 | -0.02 |
| Stochastic Oscillator | 23.12 | 19.98 |
Price Performance
Historical ComparisonAbout MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.